Wire flash
HealthSenate Panel Advances Bipartisan Bill Capping Private Insurance Insulin at $35
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
A bipartisan bill to cap the cost of insulin at $35 for people with private health insurance advanced through the Senate Health, Education, Labor and Pensions Committee on Wednesday. The measure passed by a 17-5 vote, with six Republicans joining all Democrats on the panel in support. Despite this committee approval, the legislation's future remains uncertain as it faces potential hurdles in the full Senate. The bill aims to lower out-of-pocket costs for insulin, a critical medication for diabetes patients, and represents a rare area of bipartisan cooperation on healthcare policy.
Source report
Washington — Bipartisan legislation to cap the cost of insulin at $35 for people with private health insurance advanced through a key Senate committee Wednesday, but its future remains uncertain.
The measure cleared the Senate Health, Education, Labor and Pensions Committee by a bipartisan 17-5 vote, with six Republicans joining every Democrat on the panel.
Notably...
Source
Just In NewsWestern
Part of this Story
Senate Panel Advances Bipartisan Bill Capping Private Insurance Insulin at $35